Oruka Therapeutics, Inc. ORKA Shares Reserved for Future Issuance Under Stock Plans
Shares Reserved for Future Issuance Under Stock Plans at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s shares reserved for future issuance under stock plans.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s shares reserved for future issuance under stock plans?
- Oruka Therapeutics, Inc. (ORKA) reported shares reserved for future issuance under stock plans of 34.9M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s shares reserved for future issuance under stock plans changed year-over-year?
- Oruka Therapeutics, Inc.'s shares reserved for future issuance under stock plans increased by 12.9% year-over-year, from 30.9M to 34.9M.
- What does shares reserved for future issuance under stock plans mean?
- This represents the total number of common shares authorized and set aside for future issuance to employees and directors under equity compensation plans. It provides insight into the potential future dilution of existing shareholders. Investors monitor this to assess the firm's long-term incentive structure.